IL17A and myeloid sarcoma: In this complex scenario, IL-17, one of the most representative cytokines of Psoriasis, has emerged as a key mediator in the intricate interplay that exists between inflammation, IR, and T2DM, hinting that it could also be a mediator in bridging MS and Psoriasis [65].